These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38954260)

  • 21. Neferine ameliorates nonalcoholic steatohepatitis through regulating AMPK pathway.
    Wang MY; Zhang SS; An MF; Xia YF; Fan MS; Sun ZR; Zhang LJ; Zhao YL; Sheng J; Wang XJ
    Phytomedicine; 2023 Jun; 114():154798. PubMed ID: 37031639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Xiaozhi formula attenuates non-alcoholic fatty liver disease by regulating lipid metabolism via activation of AMPK and PPAR pathways.
    You L; Wang T; Li W; Zhang J; Zheng C; Zheng Y; Li S; Shang Z; Lin J; Wang F; Qian Y; Zhou Z; Kong X; Gao Y; Sun X
    J Ethnopharmacol; 2024 Jul; 329():118165. PubMed ID: 38588984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phytochemical gallic acid alleviates nonalcoholic fatty liver disease via AMPK-ACC-PPARa axis through dual regulation of lipid metabolism and mitochondrial function.
    Zhang J; Zhang W; Yang L; Zhao W; Liu Z; Wang E; Wang J
    Phytomedicine; 2023 Jan; 109():154589. PubMed ID: 36610145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mast Cells Promote Nonalcoholic Fatty Liver Disease Phenotypes and Microvesicular Steatosis in Mice Fed a Western Diet.
    Kennedy L; Meadows V; Sybenga A; Demieville J; Chen L; Hargrove L; Ekser B; Dar W; Ceci L; Kundu D; Kyritsi K; Pham L; Zhou T; Glaser S; Meng F; Alpini G; Francis H
    Hepatology; 2021 Jul; 74(1):164-182. PubMed ID: 33434322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipidomic and transcriptomic analysis of western diet-induced nonalcoholic steatohepatitis (NASH) in female Ldlr -/- mice.
    Garcia-Jaramillo M; Spooner MH; Löhr CV; Wong CP; Zhang W; Jump DB
    PLoS One; 2019; 14(4):e0214387. PubMed ID: 30943218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IGFBP5 modulates lipid metabolism and insulin sensitivity through activating AMPK pathway in non-alcoholic fatty liver disease.
    Xiao Z; Chu Y; Qin W
    Life Sci; 2020 Sep; 256():117997. PubMed ID: 32585242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gemigliptin, a DPP4 inhibitor, ameliorates nonalcoholic steatohepatitis through AMP-activated protein kinase-independent and ULK1-mediated autophagy.
    Song Y; Yang H; Kim J; Lee Y; Kim SH; Do IG; Park CY
    Mol Metab; 2023 Dec; 78():101806. PubMed ID: 37739179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr-/- mice.
    Jump DB; Depner CM; Tripathy S; Lytle KA
    Proc Nutr Soc; 2016 Feb; 75(1):1-9. PubMed ID: 26282529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Terf2ip deficiency accelerates non-alcoholic steatohepatitis through regulating lipophagy and fatty acid oxidation via Sirt1/AMPK pathway.
    Wang Y; Liu S; Ni M; Chen Y; Chen R; Wang J; Jiang W; Zhou T; Fan S; Chang J; Xu X; Zhang Y; Yu Y; Li X; Li C
    Free Radic Biol Med; 2024 Aug; 220():78-91. PubMed ID: 38697492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.
    Lytle KA; Wong CP; Jump DB
    PLoS One; 2017; 12(4):e0173376. PubMed ID: 28422962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ginkgolide C Suppresses Adipogenesis in 3T3-L1 Adipocytes via the AMPK Signaling Pathway.
    Liou CJ; Lai XY; Chen YL; Wang CL; Wei CH; Huang WC
    Evid Based Complement Alternat Med; 2015; 2015():298635. PubMed ID: 26413119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SLC7A11-ROS/αKG-AMPK axis regulates liver inflammation through mitophagy and impairs liver fibrosis and NASH progression.
    Lv T; Fan X; He C; Zhu S; Xiong X; Yan W; Liu M; Xu H; Shi R; He Q
    Redox Biol; 2024 Jun; 72():103159. PubMed ID: 38642501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Derlin-1 promotes diet-induced non-alcoholic fatty liver disease via increasing RIPK3-mediated necroptosis.
    Wang T; Wang D; Kuang G; Gong X; Zhang L; Wan J; Li K
    Free Radic Biol Med; 2024 May; 217():29-47. PubMed ID: 38522486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of FXR and TGR5 in reversing and preventing progression of Western diet-induced hepatic steatosis, inflammation, and fibrosis in mice.
    Wang XX; Xie C; Libby AE; Ranjit S; Levi J; Myakala K; Bhasin K; Jones BA; Orlicky DJ; Takahashi S; Dvornikov A; Kleiner DE; Hewitt SM; Adorini L; Kopp JB; Krausz KW; Rosenberg A; McManaman JL; Robertson CE; Ir D; Frank DN; Luo Y; Gonzalez FJ; Gratton E; Levi M
    J Biol Chem; 2022 Nov; 298(11):102530. PubMed ID: 36209823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Demethyleneberberine attenuates non-alcoholic fatty liver disease with activation of AMPK and inhibition of oxidative stress.
    Qiang X; Xu L; Zhang M; Zhang P; Wang Y; Wang Y; Zhao Z; Chen H; Liu X; Zhang Y
    Biochem Biophys Res Commun; 2016 Apr; 472(4):603-9. PubMed ID: 26970305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic efficacy of mitochondria-targeted esculetin in the improvement of NAFLD-NASH via modulating AMPK-SIRT1 axis.
    Singuru G; Pulipaka S; Shaikh A; Balaji Andugulapati S; Thennati R; Kotamraju S
    Int Immunopharmacol; 2023 Nov; 124(Pt B):111070. PubMed ID: 37862737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preventive effects of citrulline on Western diet-induced non-alcoholic fatty liver disease in rats.
    Jegatheesan P; Beutheu S; Freese K; Waligora-Dupriet AJ; Nubret E; Butel MJ; Bergheim I; De Bandt JP
    Br J Nutr; 2016 Jul; 116(2):191-203. PubMed ID: 27197843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tartaric acid ameliorates experimental non-alcoholic fatty liver disease by activating the AMP-activated protein kinase signaling pathway.
    Pei Y; He Y; Wang X; Xie C; Li L; Sun Q; Liu L; Shan S; Wang P; Liu T; Fan X; Cong M; Jia J
    Eur J Pharmacol; 2024 Jul; 975():176668. PubMed ID: 38788791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lonicerae flos polysaccharides improve nonalcoholic fatty liver disease by activating the adenosine 5'-monophosphate-activated protein kinase pathway and reshaping gut microbiota.
    Han C; Li Z; Liu R; Zhao Z; Wang Y; Zuo X; Zhang Y; Geng Z; Huang H; Pan X; Li W
    J Sci Food Agric; 2023 Dec; 103(15):7721-7738. PubMed ID: 37439182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From overnutrition to liver injury: AMP-activated protein kinase in nonalcoholic fatty liver diseases.
    Zhao P; Saltiel AR
    J Biol Chem; 2020 Aug; 295(34):12279-12289. PubMed ID: 32651233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.